Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Gen. Rep. 2023;26:1-4. Accessed August 2, 2025. https://geniusrepo.net/index.php/1/article/view/277